Annual Accounts Payable
$7.16 M
+$5.80 M+428.82%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual accounts payable is $7.16 million, with the most recent change of +$5.80 million (+428.82%) on March 31, 2024.
- During the last 3 years, IMVT annual accounts payable has risen by +$4.72 million (+194.20%).
- IMVT annual accounts payable is now -61.59% below its all-time high of $18.63 million, reached on March 31, 2022.
Performance
IMVT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$19.82 M
-$911.00 K-4.40%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly accounts payable is $19.82 million, with the most recent change of -$911.00 thousand (-4.40%) on December 31, 2024.
- Over the past year, IMVT quarterly accounts payable has increased by +$15.91 million (+406.80%).
- IMVT quarterly accounts payable is now -25.11% below its all-time high of $26.46 million, reached on June 30, 2023.
Performance
IMVT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IMVT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +428.8% | +406.8% |
| 3 y3 years | +194.2% | +417.8% |
| 5 y5 years | +501.3% | +604.7% |
IMVT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.6% | +428.8% | -25.1% | +1758.9% |
| 5 y | 5-year | -61.6% | +501.3% | -25.1% | +1758.9% |
| alltime | all time | -61.6% | +501.3% | -25.1% | +1758.9% |
Immunovant Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $19.82 M(-4.4%) |
| Sep 2024 | - | $20.73 M(+87.8%) |
| Jun 2024 | - | $11.04 M(+54.2%) |
| Mar 2024 | $7.16 M(+428.8%) | $7.16 M(+83.0%) |
| Dec 2023 | - | $3.91 M(-47.9%) |
| Sep 2023 | - | $7.51 M(-71.6%) |
| Jun 2023 | - | $26.46 M(+1855.6%) |
| Mar 2023 | $1.35 M | $1.35 M(-90.3%) |
| Dec 2022 | - | $14.00 M(+87.7%) |
| Sep 2022 | - | $7.46 M(+599.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.07 M(-94.3%) |
| Mar 2022 | $18.63 M(+666.0%) | $18.63 M(+386.8%) |
| Dec 2021 | - | $3.83 M(-9.8%) |
| Sep 2021 | - | $4.24 M(+36.6%) |
| Jun 2021 | - | $3.11 M(+27.8%) |
| Mar 2021 | $2.43 M(+104.4%) | $2.43 M(+15.8%) |
| Dec 2020 | - | $2.10 M(-63.7%) |
| Sep 2020 | - | $5.79 M(-27.8%) |
| Jun 2020 | - | $8.01 M(+573.2%) |
| Mar 2020 | $1.19 M | $1.19 M(-57.7%) |
| Dec 2019 | - | $2.81 M |
FAQ
- What is Immunovant annual accounts payable?
- What is the all time high annual accounts payable for Immunovant?
- What is Immunovant annual accounts payable year-on-year change?
- What is Immunovant quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immunovant?
- What is Immunovant quarterly accounts payable year-on-year change?
What is Immunovant annual accounts payable?
The current annual accounts payable of IMVT is $7.16 M
What is the all time high annual accounts payable for Immunovant?
Immunovant all-time high annual accounts payable is $18.63 M
What is Immunovant annual accounts payable year-on-year change?
Over the past year, IMVT annual accounts payable has changed by +$5.80 M (+428.82%)
What is Immunovant quarterly accounts payable?
The current quarterly accounts payable of IMVT is $19.82 M
What is the all time high quarterly accounts payable for Immunovant?
Immunovant all-time high quarterly accounts payable is $26.46 M
What is Immunovant quarterly accounts payable year-on-year change?
Over the past year, IMVT quarterly accounts payable has changed by +$15.91 M (+406.80%)